Muñoz-Vendrell, A., Campoy-Díaz, S., Valín-Villanueva, P., Casas-Limón, J., Fernández-Lázaro, I., González-García, N., . . . Huerta-Villanueva, M. (2025). Atogepant after anti-CGRP monoclonal antibodies failure in migraine: A multicenter real-world study of effectiveness, safety, persistence and predictors of response. BMC.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Muñoz-Vendrell, A., et al. Atogepant After Anti-CGRP Monoclonal Antibodies Failure in Migraine: A Multicenter Real-world Study of Effectiveness, Safety, Persistence and Predictors of Response. BMC, 2025.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Muñoz-Vendrell, A., et al. Atogepant After Anti-CGRP Monoclonal Antibodies Failure in Migraine: A Multicenter Real-world Study of Effectiveness, Safety, Persistence and Predictors of Response. BMC, 2025.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.